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Objective: Myocardial viability and left ventricular dyssynchrony are important predictors of long-term out-
comes in patients with ischemic left ventricular dysfunction. The objective of this study was to test the hypothesis
that assessment of myocardial viability and left ventricular dyssynchrony will predict perioperative mortality in
high-risk patients with ischemic left ventricular dysfunction having coronary artery bypass surgery.
Methods: The study consisted of 79 consecutive patients with ischemic cardiomyopathy (age 65 9 years; 81%
men; ejection fraction 30%  6%) and logistic European system for cardiac operative risk evaluation>10%
having coronary artery bypass surgery.Myocardial viability was assessed by delayed contrast-enhanced magnetic
resonance imaging. Left ventricular dyssynchrony was calculated using tissue Doppler from measurements of re-
gional electromechanical coupling times in left ventricular basal segments before coronary artery bypass surgery.
Results: Twenty (25.3%) patients died within 30 days following coronary artery bypass surgery. Survivors
(n ¼ 59) showed a larger extent of viable myocardium (6.9  3.6 viable segments vs 3.4  3.3 viable segments,
P<.001) and smaller left ventricular dyssynchrony (75 5ms vs 179 83ms, P<.001) than nonsurvivors. The
presence of significant dyssynchrony (105 ms) and absence of myocardial viability (<5 viable segments) inde-
pendently predicted 30-day mortality with hazard ratio 3.26, 95% confidence interval 1.61 to 8.33 (P<.01) and
hazard ratio 1.72, 95% confidence interval 1.59 to 1.89 (P< .01), respectively. All but 2 patients (94.1%) with
viable myocardium and without left ventricular dyssynchrony survived coronary artery bypass surgery as com-
pared with only 12 (52.2%) patients with nonviable myocardium and severe dyssynchrony (P< .001).
Conclusions: In high-risk patients with ischemic left ventricular dysfunction having coronary artery bypass sur-
gery, both myocardial viability and left ventricular dyssynchrony are important predictors of perioperative out-
come. Assessment of myocardial viability and left ventricular dyssynchrony should be a routine part of the
preoperative evaluation of these patients.
Acquired Cardiovascular Disease Maruskova et alMyocardial revascularization using coronary artery bypass
surgery (CABG) is associated with improved long-term sur-
vival in some patients with coronary artery disease and se-
vere left ventricular (LV) dysfunction compared with
conservative management.1,2 However, in these patients,
the potential long-term benefits of revascularization must
be weighed against the high periprocedural risks.1-3 The
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(EuroSCORE) is a widely accepted scoring system used
to predict immediate postoperative outcomes after
CABG.4,5 High EuroSCORE levels have been associated
with high perioperative mortality. However, in patients
with severe LV dysfunction, additional factors not inte-
grated in the EuroSCORE system, such as the extent of
viable myocardium or cardiac dyssynchrony, may be
important determinants of perioperative outcomes.1-3,6
Several studies1,2,6 have demonstrated a strong relationship
between the amount of myocardial viability and survival
following CABG surgery in patients with ischemic LV
dysfunction. In one of our recent studies,3 the presence of
severe LV dyssynchrony prior to CABG was significantly
associated with elevated 30-day mortality in patients having
moderate systolic heart failure. This suggests that the
predictive accuracy of the EuroSCORE may be lower in
patients with ischemic LV dysfunction compared with pa-
tients with normal systolic function. The reduced predictive
value of the EuroSCORE in patients with LV dysfunction
may complicate clinical decision making, particularly in
critically ill patients at high perioperative risk.ery c July 2009
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CABG ¼ coronary artery bypass surgery
CI ¼ confidence interval
EuroSCORE ¼ European system for cardiac
operative risk evaluation
HR ¼ hazard ratio
LV ¼ left ventricular
NYHA ¼ New York Heart Association
ROC ¼ receiver operating characteristics
STS ¼ Society of Thoracic Surgeons
mortality risk score
Therefore, the objective of the present study was to test the
hypothesis that assessment of myocardial viability and LV
dyssynchrony will predict perioperative mortality and
will improve the predictive accuracy of the EuroSCORE
in high-risk patients with ischemic LV dysfunction having
CABG.
METHODS
Patients
Between January 1, 2005 and December 31, 2005, 1252 patients had
CABG at our institutions. The prospective study consisted of 79 (6.3%)
consecutive patients (age 65  9 years; 81% men) having isolated
CABG who met the following criteria: (1) stable LV dysfunction (LV ejec-
tion fraction<40%, for at least 3 months; to be eligible for the study, the
presence of qualifying LV dysfunction had to be already documented at
least 3 months before enrollment); (2) standard (3 months) heart failure
medication including angiotensin-converting enzyme/AT1 inhibitors and
ß-blockers if tolerated; (3) logistic EuroSCORE>10%. Patients with acute
coronary syndrome or hospitalization for worsening heart failure in the pre-
vious 3 months; any valvular heart disease requiring surgery, pacemakers,
or internal defibrillators; and contraindications for magnetic resonance
were excluded from the study. All patients recruited for the study had
CABG surgery as the sole procedure. None of the patients had concomitant
LV remodeling, aneurysmectomy, mitral valve repair, or the MAZE proce-
dure. The study was approved by the ethical committee. All patients gave
a written informed consent prior to participation.
Protocol
In the week leading up to CABG surgery, each patient had assessment of
myocardial viability through contrast enhanced magnetic resonance imag-
ing; LV dyssynchrony was evaluated using pulsed-wave tissue Doppler.
Perioperative risk was calculated using the logistic EuroSCORE. Patients
were then followed for 30 days postsurgery to assess 30-day mortality.
Assessment of Myocardial Viability by Magnetic
Resonance Imaging
Delayed contrast-enhanced electrocardiogram-gatedmagnetic resonance
images (1.5-T scanner Siemens Symphony, Erlangen, Germany) were ac-
quired using a phased-array receiver coil during breath-holds.7 Short-axis
images were acquired every 5 mm from base to apex. Imaging was done
20 minutes after intravenous injection of a gadolinium-based contrast agent
(for dose of 0.2 mmol/kg). Images were analyzed off-line by an independent
operator. The extent of hyperenhanced tissue was assessed in each segment
(16-segment model) of the left ventricle. Segments with50% of transmu-
ral hyperenhancement were considered viable.6The Journal of Thoracic andAssessment of LV Dyssynchrony by Tissue Doppler
Echocardiography
Echocardiograms were performed using a standard commercial ultra-
sound system equipped with tissue Doppler imaging (Vivid 7, Vingmed-
General Electric, Horten, Norway). Tissue Doppler was performed in
pulsed-wave mode. In brief, in 3 apical (4-, 3-, and 2-chamber) views, lon-
gitudinal myocardial velocities were recorded in 6 basal segments of the left
ventricle.3 Gain and filters were adjusted to obtain an optimal tissue signal.
Myocardial velocities were recorded at end expiration at a sweep speed of
100 mm/s. All recordings were stored both in digital (raw data) format
and on S-VHS videotape for off-line analysis. The mean from 3 consecutive
beats was taken for each measurement. Echocardiographers were blinded to
clinical follow-up data.
To assess the extent of LV dyssynchrony, the time delay between the on-
set of QRS complex on the surface electrocardiogram and the onset of the
systolic velocity waves on the tissue Doppler imaging recordings were as-
sessed in each basal LV segment.8 Dyssynchrony was calculated as the dif-
ference between the shortest and the longest time delay in the 6 basal
segments. Hence, LV dyssynchrony represents a delay in the onset of con-
traction between the segment with the earliest and the segments with the lat-
est systolic wall motion. Intra- and interobserver variability for the
assessment of LV dyssynchrony was 7.1% and 8.2%, respectively.
EuroSCORE
EuroSCORE is a risk stratification system for the prediction of early mor-
tality in patients having cardiac surgery.5 It has been in use since 1999. The
EuroSCORE has a total of 17 factors, consisting of 9 patient-related factors,
4 factors reflecting the preoperative cardiac status, and 4 factors that depend
on the timing and nature of the surgical procedure. Together, the scores pre-
dict an approximate percentage for mortality.
Statistical Analysis
Data are presented as mean  standard deviation. Two-sided unpaired
Student t test was used as appropriate. The Fisher exact test was used to
compare categorical variables. The receiver-operating characteristics
(ROC) curves were constructed to assess optimal cutoff values for the num-
ber of dysfunctional viable segments and LV dyssynchrony to predict the
30-day mortality. Independent predictors of the 30-day mortality were iden-
tified using the Cox proportional hazard model and expressed as a hazard
ratio (HR) and 95% confidence interval (CI). All analyses were conducted
using SPSS software (version 13).
RESULTS
Baseline Characteristics
Twenty (25.3%) patients died within 30 days following
CABG (in-hospital deaths). All patients died of pump failure
leading to low-output syndrome, multiorgan failure, or sep-
sis. No patient died of arrhythmias. Table 1 shows baseline
characteristics in survivors and nonsurvivors. All patients
had left main (19%) or 3-vessel disease (81%). The major-
ity (86%) of included patients showed symptoms of conges-
tive heart failure and 47.8% had severe heart failure (New
York Heart Association [NYHA] class III–IV). Angina pec-
toris was an indication for CABG in 72% of patients, and
isolated heart failure symptoms in 28% of patients. Prior
to CABG, survivors had milder heart failure symptoms
and higher LV ejection fractions (both P< .05) and tended
to have lower systolic pulmonary artery pressure (P ¼ .051)
than patients who died. Also, survivors had significantlyCardiovascular Surgery c Volume 138, Number 1 63
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Survivors (n ¼ 59) Nonsurvivors (n ¼ 20) P value (survivors vs nonsurvivors)
Age (y) 65  9 66  10 NS
Male sex, n (%) 47 (80) 17 (85) NS
Diabetes mellitus, n (%) 19 (28) 7 (35) NS
Hypertension, n (%) 45 (76) 15 (75) NS
Obesity, n (%) 14 (24) 6 (30) NS
Prior myocardial infarction, n (%) 44 (74) 12 (60) NS
Chronic obstructive pulmonary disease, n (%) 15 (25) 4 (20) NS
Prior stroke, n (%) 6 (10) 3 (15) NS
Peripheral vascular disease, n (%) 16 (27) 5 (25) NS
Serum creatinine>200 mmol/L, n (%) 6 (10) 4 (20) NS
Angina pectoris, n (%) 44 (75) 13 (65) NS
NYHA functional class III–IV, n (%) 23 (34) 14 (70) .021
Congestive heart failure, n (%) 50 (85) 18 (90) NS
Preoperative medication
Loop diuretics 52 (88) 19 (95) NS
ACE/AT1 inhibitors 47 (80) 15 (75) NS
ß-blockers 44 (75) 14 (70) NS
Digoxin 16 (27) 6 (30) NS
Left main disease, n (%) 11 (19) 4 (20) NS
Three-vessel disease, n (%) 48 (81) 16 (80) NS
LV ejection fraction (%) 30  6 27  5 .042
Systolic pulmonary artery pressure (mm Hg) 41  8 45  10 .051
Dysfunctional viable segments (n) 6.9  3.6 3.4  3.3 <.001
Pre-CABG LV dyssynchrony (m)s 75  55 179  83 <.001
Logistic EuroSCORE (%) 14.5  4.6 14.3  3.8 NS
ACE, Angiotensin-converting enzyme; CABG, coronary artery bypass surgery; EuroSCORE, European system for cardiac operative risk evaluation; LV, left ventricular; NYHA,
New York Heart Association.more viable myocardium and less LV dyssynchrony (both
P< .001) than nonsurvivors. In contrast, the EuroSCORE
and other baseline clinical characteristics were similar in
both groups.
Operative Data and 30-Day Outcomes
Operative data and30-dayoutcomes are detailed inTable 2.
All patients had on-pump CABG.Mean bypass and ischemic
timeswere similar in both groups. Complete revascularization
was achieved in the majority (84%) of patients. Post-CABG,
nonsurvivors hadahigher prevalenceof low-output syndrome
and renal failure requiring dialysis. In contrast, prevalence of
perioperative myocardial infarction, stroke, bleeding, and
sepsis was similar.
Prediction of 30-Day Mortality
The ROC curves were constructed to analyze the accuracy
ofbaselinevariables inpredicting30-daymortality (Figure1).
Preoperative LV dyssynchrony, with a cutoff value of 105
ms (n ¼ 23), showed the highest accuracy to predict clinical
events. Fourteen (61%) of 23 patients with severe dyssyn-
chrony (105ms) died compared with 6 (11%) of the 56 pa-
tients without dyssynchrony. The sensitivity and specificity
of this criterion to identify nonsurvivors were 70% and
85%, respectively. The number of dysfunctional but viable
segments, with a cutoff value<5 segments, had lower accu-64 The Journal of Thoracic and Cardiovascular Surgracy (area under the curve 0.71), and the EuroSCORE failed
to differentiate between survivors and nonsurvivors (area
under the curve 0.47). In the Cox regression analysis, LV
dyssynchrony 105ms and<5dysfunctional but viable seg-
ments were identified as independent predictors of 30-day
mortality with HR 3.26, 95% CI 1.61 to 8.33 (P< .01) and
HR 1.72, 95% CI 1.59 to 1.89 (P< .01), respectively.
Table 3 shows the EuroSCORE-derived predicted mortal-
ity versus real 30-day mortality in patients divided accord-
ing to the presence or absence of myocardial viability and
LV dyssynchrony. In the study group as a whole, 30-day
mortality was significantly higher than predicted by the
EuroSCORE (P ¼ .02). In patients with significant myocar-
dial viability, EuroSCORE predictions and the real mortal-
ity were similar. In contrast, EuroSCORE significantly
underestimated the perioperative risk in patients without vi-
able myocardium, in whom the 30-day mortality was 3
times higher than EuroSCORE predictions (P ¼ .02). In
the subset of patients with a large extent of myocardial via-
bility and without LV dyssynchrony, EuroSCORE severely
overestimated the risk, with real mortality being 59% lower
than EuroSCORE predictions. All but 2 patients (94.1%)
with viable myocardium and without LV dyssynchrony sur-
vived CABG surgery, compared with only 12 (52.2%) pa-
tients with nonviable myocardium and severe dyssynchrony
(P< .001).ery c July 2009
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Survivors (n ¼ 59) Nonsurvivors (n ¼ 20) P value (survivors vs nonsurvivors)
Preoperative intra-aortic balloon pump, n (%) 0 0 NS
On-pump CABG surgery, n (%) 59 (100) 20 (100) NS
Cardiopulmonary bypass time (min) 122  48 126  50 NS
Ischemic time (min) 90  40 95  46 NS
Number of grafts 3.3  0.9 3.5  1.0 NS
Complete revascularization, n (%) 50 (85) 16 (80) NS
Low-output syndrome, n (%) 19 (32) 20 (100) <.001
Postoperative intra-aortic balloon pump, n (%) 17 (29) 18 (90) <.001
Perioperative myocardial infarction, n (%) 2 (3) 1 (5) NS
Perioperative stroke, n (%) 2 (3) 1 (5) NS
Bleeding requiring reoperation, n (%) 3 (5) 1 (5) NS
Sepsis, n (%) 2 (3) 3 (15) NS
Renal failure requiring dialysis, n (%) 6 (10) 7 (35) .016
CABG, Coronary artery bypass surgery.ADISCUSSION
The present study enrolled high-risk patientswith ischemic
LVdysfunction havingCABG. In these patients, who had ex-
cessive perioperative mortality risks, the decision regarding
the optimal therapeutic strategy is often very difficult. Our
study found that the EuroSCORE alone was unable to dis-
criminate 30-day survivors from nonsurvivors. Patients
who died had lower LV ejection fraction, higher NYHA
class, less myocardial viability, and more LV dyssynchrony
compared with survivors. Myocardial viability and LV
dyssynchrony turned out to be the strongest predictors of peri-
operative outcome. The absence of viable myocardium tri-
pled the risk of perioperative death compared with
EuroSCORE-predicted mortality. The presence of viable
myocardium with concomitant absence of LV dyssynchrony
was associated with reduced mortality compared with Euro-
SCORE estimates. Hence, in high-risk patients with ischemic
LV dysfunction, the choice of optimal therapeutic strategies
should be based both on the EuroSCORE and on the assess-
ment of myocardial viability and LV dyssynchrony.Prediction of Perioperative Outcome in Patients with
Ischemic LV Dysfunction
EuroSCORE has been validated as a system to predict im-
mediate postoperative outcome after adult cardiac surgery.5
Both the additive and logistic EuroSCORE have been
proven accurate in identifying individuals at high risk of
the perioperative death in the general population of patients
having cardiac surgery.4,5 However, in the present study, the
accuracy of the EuroSCORE alone to identify 30-day non
survivors was low. This suggests that although reliable
with regard to the general population, EuroSCORE may
be less reliable in specific subsets of patients, such as those
with LV dysfunction. Dysfunctional LV myocardium con-
sists of variously scarred myocardium, hibernating and
stunned muscle, and dyssynchrony. Although all these pa-
rameters were shown to be important predictors of perioper-
ative and long-term outcome, they are not incorporated into
the EuroSCORE system.1-3,6,9,10 In the present study, the
presence of viable myocardium stabilized perioperative
mortality at the level predicted by EuroSCORE. In contrast,FIGURE 1. The receiver-operating characteristic curves to predict the 30-daymortality for left ventricular dyssynchrony, myocardial viability, and the Euro-
SCORE. AUC, Area under curve; EuroSCORE, European system for cardiac operative risk evaluation; NPV, negative predictive value; Sp, specificity;
Ss, sensitivity.
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Acquired Cardiovascular Disease Maruskova et alTABLE 3. EuroSCORE-derived predicted mortality versus real 30-day mortality according to the myocardial viability and LV dyssynchrony
All patients (n ¼ 79) VIAB (n ¼ 48) NonVIAB (n ¼ 31) VIAB noDYS (n ¼ 34)
EuroSCORE-predicted mortality (%) 14.4 14.5 14.3 14.1
Real 30-d mortality (%) 25.3* 14.6 41.9* 5.9
Percentage 30-d mortality risk change by
assessment of VIAB and/or DYS prior to
CABG (%)
NA No change [ 293 Y 59
CABG, Coronary artery bypass surgery; EuroSCORE, European system for cardiac operative risk evaluation; LV, left ventricular; NonVIAB,<5 viable segments; VIAB, 5 viable
segments; VIAB noDYS, LV dyssynchrony<105 ms. *P< .05 EuroSCORE-predicted versus real 30-d mortality.the absence of viability was associated with excessive mor-
tality risk, which was severely underestimated by Euro-
SCORE. Of note, the pre-CABG assessment of myocardial
viability was not used for patient selection. In our study, pa-
tient selection for CABG surgery was guided by symptoms
and the extent of coronary atherosclerosis. All patients with
angina were considered to be for eligible for surgery. CABG
surgery has been shown to improve survival in patients with
angina compared with conservative therapy.11 In case of iso-
lated heart failure symptoms, the decision to perform CABG
surgery was guided by the extent of coronary artery disease.
All patients with left main or proximal 3-vessel disease were
considered eligible for myocardial revascularization regard-
less of presenting symptoms or viability status. Of note, in
the Coronary Artery Surgery Study registries, the patients
with left main or proximal 3-vessel disease were shown to
gain the greatest survival benefit from myocardial revascu-
larization compared with medical therapy.11 The role of vi-
ability studies in the management of patients with ischemic
LV dysfunction having CABG remains unclear. Many ob-
servational studies demonstrated low benefit to performing
revascularization in patients without viable myocardium.1,2
However, in the majority of these studies, the viability status
was not used for the selection of patients for the CABG sur-
gery. In contrast, several studies12,13 showed similar out-
comes after CABG regardless of viability status, and also
patients with nonviable myocardium had lower long-term
mortality compared with medical therapy. Thus, in the ab-
sence of any randomized data and conflicting results from
observational studies, it is difficult to decline revasculariza-
tion in patients with left main or proximal 3-vessel disease
based only on the absence of viable myocardium. Yet the
data from the present study suggest that in the high-risk pa-
tients with heart failure and nonviable myocardium, an alter-
native approach to surgical revascularization should be
strongly considered, such as palliative percutaneous coro-
nary intervention or medical therapy.
Cardiac dyssynchrony complicates the course of systolic
heart failure. Onset of dyssynchrony is associated with a de-
terioration of LV function and worsens the prognosis.9,10
We have previously demonstrated a strong relationship be-
tween the extent of LV dyssynchrony and 30-day outcome
in patients with moderated heart failure having CABG.3
The present study extends these findings to high-risk indi-66 The Journal of Thoracic and Cardiovascular Surgviduals with ischemic LV dysfunction. We found that the
absence of dyssynchrony halved the mortality predicted by
EuroSCORE in patients with viable myocardium. In other
words, the presence of significant dyssynchrony eliminated
the advantage associated with increased viable myocardial
mass. Patients with the most severe dyssynchrony had the
worst outcomes.
The mechanism underlying the adverse effects of LV dys-
synchrony on immediate postoperative outcome might be
explained as follows: the prevalence of significant LV dys-
synchrony in the cohort of patients with ischemic LV dys-
function referred for CABG ranges from 36% to 51%.3
The reduction of ischemia by CABG is associated with re-
synchronization of contraction in only 29% of patients
with a high degree of preoperative dyssynchrony.3 Never-
theless, these patients show prompt recovery of contractile
function after switching off the cardiopulmonary bypass
and have uncomplicated postoperative courses. In contrast,
patients with persistent dyssynchrony (71%) do poorly fol-
lowing termination of cardiopulmonary bypass. We ob-
served that some segments were not contracting because
they were nonviable, and the viable segments started con-
tracting but in an uncoordinated (dyssynchronous) fashion.
The contraction of some of these viable segments were so
delayed that it occurred during diastole, which meant con-
traction was taking place while the aortic valve was closed.
Therefore, it was not surprising that these patients frequently
had persistent low-output syndrome and died from cardiac
or multiorgan failure within a few days. Dyssynchrony cor-
rection, with biventricular pacing, has been shown to im-
prove contractile function and survival in patients with
advanced systolic heart failure.14,15 Of note, in our study,
presence of severe heart failure was associated with an in-
creased 30-day mortality. One may speculate that in patients
with significant LV dysfunction and LV dyssynchrony, im-
plantation of a biventricular pacemaker prior to CABG or
temporal biventricular pacing immediately after surgery
could improve postoperative outcomes.
Limitations
In the present study, the perioperative mortality rate was
higher compared with other studies in patients with LV
dysfunction.16-22 The high mortality rate observed in the
present study may be related to the selection criteriaery c July 2009
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nary artery disease (left main [LM] 19%; three-vessel dis-
ease [3-VD] ¼ 81%) and EuroSCORE > 10% were
enrolled in the study. Second, the majority (86%) of in-
cluded patients had congestive heart failure symptoms
and 47.8% had severe heart failure (NYHA class III–
IV). Of note, nonsurvivors had higher prevalence of
NYHA class III to IV heart failure than survivors. The sig-
nificant proportion of enrolled patients with severe heart
failure could be explained by using high EuroSCORE as
the main selection criterion. Several authors showed that
the pre-CABG presence of congestive heart failure is one
of the main independent predictor of operative mortal-
ity.17-20 Of note, these studies with lower 30-day mortality
enrolled smaller proportion of patients with heart failure
compared with the present study.16-22 Finally, 39% of pa-
tients had nonviable myocardium. In a high-risk patient
with low ejection fraction and significant comorbidities, as-
sessment of myocardial viability is sometimes used as a ba-
sis for clinical decision making as to whether or not to
perform CABG surgery. Patients with nonviable myocar-
dium are likely to be declined by cardiosurgeon. In the
present study, such selection was not performed, and hence
the prevalence of patients with nonviable myocardium may
be higher than in the previous reports. Corroborating this
hypothesis, in our series, the excessive mortality was ob-
served predominantly in patients with nonviable myocar-
dium. In contrast, the remaining patients showed
mortality in the range of 10% to 15%, which corresponds
with the preoperative expectations in high-risk patients
with significant LV dysfunction.
In the present study, the perioperative risk was assessed
using the EuroSCORE system, which is a standard system
used both in the Czech Republic and within Europe. How-
ever, there are also other risk prediction models such as the
Society of Thoracic Surgeons mortality risk score (STS),23
which is often used by North American surgeons. Despite
some differences between the EuroSCORE and the STS
model, both risk scores are very similar in predictive per-
formance, at least in patients having isolated CABG sur-
gery. Previous work demonstrated that the EuroSCORE
was very reliable in assessing operative risk in the North
American population.24 Moreover, several studies showed
superior accuracy of the EuroSCORE to predict periopera-
tive mortality compared with the STS score.25,26 Nashef
and colleagues24 found that the EuroSCORE-predicted
mortality was remarkably similar to the observed mortality
in a sample of over one-half million patients having CABG
or valve surgery. They recommended the use of the Euro-
SCORE over the STS score. Another advantage of the
EuroSCORE may rest on ease of its use. The STS model,
with more than 50 clinical variables, is a very comprehen-
sive tool to implement at the bedside. In contrast, the Euro-
SCORE is very easy to use at the bedside. This suggestsThe Journal of Thoracic andthat despite its simplicity, the EuroSCORE provides com-
parably accurate assessment of perioperative risk as the
more complex STS score.
In conclusion, the findings of the present study indicate
that in high-risk patients with ischemic LV dysfunction hav-
ing CABG, both myocardial viability and LV dyssynchrony
are important predictors of perioperative outcome. A combi-
nation of EuroSCORE, viability, and dyssynchrony testing
allows for superior risk stratification prior to surgical revas-
cularization as compared with the EuroSCORE alone. For
this reason, assessment of myocardial viability and LV dys-
synchrony should become a routine part of the preoperative
evaluation of these patients.
We are indebted to Martina Havlikova for her excellent admin-
istrative support throughout the study.
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